Our common goal is to realize the potential for AI and machine learning in healthcare
Board of Directors
Chairperson of the Board
Mustaqhusain Kazi
Global Head of Informatics Strategy and Digital Innovation, Roche/Genentech
Vice-Chairperson
Stacie Calad-Thomson, Ph.D.
Chief Strategy Officer and Head of Drug Discovery, BioSymetrics
Treasurer
James Zanewicz, JD, LLM, RTTP
Chief Business Officer, Tulane University School of Medicine
Secretary
Maria Luisa Pineda, Ph.D.
Co-Founder & CEO, Envisagenics
Ex-Officio
Naheed Kurji
President and CEO, Cyclica
At Large
Sarah Benson-Konforty, M.D.
Advisory Board & Investor Relations, Pepticom
At Large
Esther Bleicher
General Counsel. Hello Heart
At Large
Arnaub Chatterjee
Chief Product and Solutions Officer, TriNetX
At Large
Joseph Lehár, Ph.D.
SVP, R&D Strategy, OWKIN
At Large
Bruce Press
Principal, ZS
At Large
Rafael Rosengarten, Ph.D.
Co-Founder & CEO, Genialis
At Large
Angela Wilkens, Ph.D.
Executive Director, Ken Kennedy Institute, Rice University
At Large
Alex Zhavoronkov, Ph.D.
CEO, Insilico Medicine
AAIH Working Group Chairs
Data Working Group (DWG)
Andrew Nguyen, Section Lead, Medical Informatics, Genentech
Shalini Trefzer, Global AI / Data Lead, Microsoft
Regulatory Working Group (RWG)
Esther Bleicher, SVP, R&D Strategy, OWKIN
Arnaub Chatterjee, Chief Product and Solutions Officer, TriNetX
Paul Howard, Senior Director Public Policy, Amicus Therapeutics
Senior Advisor to RWG
